HSING-CHUN HSIEH: Open Payments
NPI 1003408642 · ALHAMBRA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 4 payments from 4 companies in 2025. Trend: 2023 $4,334 · 2024 $1,303 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $135 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| ABBVIE INC. | 1 | $22 |
| PFIZER INC. | 1 | $17 |
Products named: INGREZZA, EPKINLY, ELREXFIO.
Industry payments across CA — which companies pay providers there.
